Welcome to CDC stacks | Prevalence of Hepatitis E Virus Antibodies, Israel, 2009–2010 - 29305 | Emerging Infectious Diseases
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Prevalence of Hepatitis E Virus Antibodies, Israel, 2009–2010
Filetype[PDF-317.02 KB]


Details:
No Related Documents.
You May Also Like:
  1. Epidemiology of Human T-cell Lymphotropic Virus Type 1 Infection in Blood Donors, Israel
    Published:
    Jul 2009
    Source:
    Emerg Infect Dis. 15(7):1116-1118.
    Description:
    The prevalence of infection with human T-cell lymphotropic virus type 1 (HTLV-1) in blood donors from Israel is 1 infection/100,000 persons. In donors originating from Eastern Europe, the Middle East, and Latin America, prevalences are 7.7, 14.6, and...
    File Type:
    Filetype[PDF - 424.43 KB]
  2. Substantial decline in hepatitis B virus infections following vaccine introduction in Tajikistan
    Personal Author:
    Khetsuriani, Nino; Tishkova, Faina; Jabirov, Shamsidin; Wannemuehler, Kathleen; Kamili, Saleem; Pirova, Zulfiya; Mosina, Liudmila; Gavrilin, Eugene; Ursu, Pavel; Drobeniuc, Jan;
    Published:
    Jun 10 2015
    Source:
    Vaccine. 33(32):4019-4024.
    Description:
    Background : Tajikistan, considered highly endemic area for hepatitis B virus (HBV) in a pre-vaccine era, introduced hepatitis B vaccine in 2002 and reported ≥80% coverage with three doses of hepatitis B vaccine (HepB3) since 2004. However, the imp...
    File Type:
    Filetype[PDF - 180.04 KB]
  3. Dengue seroconversion among Israeli travelers to tropical countries.
    Personal Author:
    Potasman, I.; Srugo, I.; Schwartz, E.;
    Published:
    1999 Nov-Dec
    Source:
    Emerg Infect Dis. 5(6):824-827.
    Description:
    We tested for dengue seroconversion among 104 Israeli young adults who traveled to tropical countries for at least 3 months. Seven (6. 7%) seroconverted during travel; four (3.8%) had immunoglobulin (Ig) M antibodies; one was symptomatic with borderl...
    File Type:
    Filetype[PDF - 64.95 KB]
  4. Molecular Epidemiology and Evolution of West Nile Virus in North America
    Personal Author:
    Mann, Brian R.; McMullen, Allison R.; Swetnam, Daniele M.; Barrett, Alan D. T.;
    Published:
    Oct 16 2013
    Source:
    Int J Environ Res Public Health. 2013; 10(10):5111-5129.
    Description:
    West Nile virus (WNV) was introduced to New York in 1999 and rapidly spread throughout North America and into parts of Central and South America. Displacement of the original New York (NY99) genotype by the North America/West Nile 2002 (NA/WN02) geno...
    File Type:
    Filetype[PDF - 510.81 KB]
  5. West Nile outbreak in horses in southern France, 2000: the return after 35 years.
    Personal Author:
    Murgue, B.; Murri, S.; Zientara, S.; Durand, B.; Durand, J. P.; Zeller, H.;
    Published:
    2001 Jul-Aug
    Source:
    Emerg Infect Dis. 7(4):692-696.
    Description:
    On September 6, 2000, two cases of equine encephalitis caused by West Nile (WN) virus were reported in southern France (Hérault Province), near Camargue National Park, where a WN outbreak occurred in 1962. Through November 30, 76 cases were laborato...
    File Type:
    Filetype[PDF - 106.95 KB]